Avenue Therapeutics Inc (ATXI)

1.91 -0.04 (-2.05%) USD  |  NASDAQ  |  Nov 14, 10:48
More

Avenue Therapeutics Total Liabilities (Quarterly): 1.161M for June 30, 2024

Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2016. Upgrade now.
Date Value
June 30, 2024 1.161M
March 31, 2024 1.412M
December 31, 2023 1.196M
September 30, 2023 5.024M
June 30, 2023 7.812M
March 31, 2023 10.60M
December 31, 2022 3.579M
September 30, 2022 0.614M
June 30, 2022 0.407M
March 31, 2022 0.797M
December 31, 2021 0.509M
September 30, 2021 0.848M
June 30, 2021 0.549M
March 31, 2021 0.469M
December 31, 2020 0.886M
September 30, 2020 1.118M
Date Value
June 30, 2020 1.23M
March 31, 2020 0.923M
December 31, 2019 2.115M
September 30, 2019 1.917M
June 30, 2019 1.773M
March 31, 2019 9.412M
December 31, 2018 5.156M
September 30, 2018 2.469M
June 30, 2018 4.419M
March 31, 2018 5.92M
December 31, 2017 2.79M
September 30, 2017 1.99M
June 30, 2017 7.549M
March 31, 2017 9.138M
December 31, 2016 8.445M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

0.407M
Minimum
Jun 2022
10.60M
Maximum
Mar 2023
2.171M
Average
1.118M
Median
Sep 2020

Total Liabilities (Quarterly) Benchmarks

Fortress Biotech Inc 160.28M
Checkpoint Therapeutics Inc 21.42M
Journey Medical Corp 53.89M
NovaBay Pharmaceuticals Inc 4.542M
Palatin Technologies Inc 10.85M

Total Liabilities (Quarterly) Related Metrics

Total Assets (Quarterly) 4.988M
Shareholders Equity (Quarterly) 4.764M